Skip to main content
SpringerLink
Log in

In vitro activity of azithromycin and dirithromycin against axenic Entamoeba histolytica

  • Brief Report
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. World Health Organization (1997) Amoebiasis. Wkly Epidemiol Rec 72:97–100

    Google Scholar 

  2. Orzozco E, Lopez C, Gomez C, Perez DG, Marchat L, Banuelos C, Delgadillo DM (2002) Multidrug resistance in the protozoan parasite Entamoeba histolytica. Parasitol Int 51:353–359

    Article  PubMed  Google Scholar 

  3. Samarwickrema NA, Brown DM, Upcroft JA, Thammapalerd N, Upcroft P (1997) Involvement of superoxide dismutase and pyruvate:ferredoxin oxidoreductase in mechanisms of metronidazole resistance in Entamoeba histolytica. J Antimicrob Chemother 40:833–840

    Article  PubMed  Google Scholar 

  4. Ravdin JI, Skilogiannis J (1989) In vitro susceptibility of Entamoeba histolytica to azithromycin, CP-63,956, erythromycin, and metronidazole. Antimicrob Agents Chemother 33:960–962

    CAS  PubMed  Google Scholar 

  5. Araujo FG, Guptill DR, Remington JS (1988) Azithromycin, a macrolide antibiotic with potent activity against Toxoplasma gondii. Antimicrob Agents Chemother 32:755–757

    CAS  PubMed  Google Scholar 

  6. Diamond LS, Harlow DR, Cunnick CC (1987) A new medium for the axenic cultivation of Entamoeba histolytica and other Entamoeba. Trans R Soc Trop Med Hyg 72:431–432

    Article  Google Scholar 

  7. Hubert W, Koella JC (1993) A comparison of three methods of estimation EC50 in studies of drug resistance of malaria parasites. Acta Tropica 55:257–261

    Article  PubMed  Google Scholar 

  8. Cedeño JR, Krogstad DJ (1983) Susceptibility testing of Entamoeba histolytica. J Infect Dis 148:1090–1096

    PubMed  Google Scholar 

  9. Eubank WB, Reeves RE (1981) Growth inhibition of axenic Entamoeba histolytica by tubercindin and ara-A. Am J Trop Med Hyg 30:900–904

    CAS  PubMed  Google Scholar 

  10. Georgeopoulos A, Linnau KF, Buxbaum A, Coste C, Ramirez de Los Santos MA, Shabpar A, Graninger W (2001) Efficay of macrolides vs. metronidazole against Entameoba histolytica clinical isolates. Wien Klin Wochenschr 113:593–596

    PubMed  Google Scholar 

Download references

Author information

Author notes

  1. S. Ranque

    Present address: Laboratoire de Parasitologie-Mycologie, Faculté de Médecine, 27 Boulevard Jean Moulin, 13385, Marseille Cedex 05, France

Authors and Affiliations

  1. Institut de Parasitologie et Pathologie tropicale, 3 rue Koeberlé, 67000, Strasbourg, France

    S. Ranque, B. Molet & E. Candolfi

  2. Service des Maladies infectieuses et tropicales, Hôpitaux universitaires, 67091, Strasbourg Cedex, France

    D. Christmann

Authors
  1. S. Ranque
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. Molet
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D. Christmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. E. Candolfi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. Ranque.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ranque, S., Molet, B., Christmann, D. et al. In vitro activity of azithromycin and dirithromycin against axenic Entamoeba histolytica. Eur J Clin Microbiol Infect Dis 23, 932–933 (2004). https://doi.org/10.1007/s10096-004-1250-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-004-1250-1

Keywords

Search

Navigation